Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres

Keishiro Tomoda; Kimiko Makino

doi:10.1016/j.colsurfb.2006.11.030

journal article Mar 01, 2007

Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres

Keishiro Tomoda Kimiko Makino

Colloids and Surfaces B: Biointerfaces Vol. 55 No. 1 pp. 115-124 · Elsevier BV

View at Publisher Save 10.1016/j.colsurfb.2006.11.030

Topics

No keywords indexed for this article. Browse by subject →

References

31

[1]

World Health Organization, Western Pacific Regional Office: Pacific strategic plan to STOP TB, 2000.

[2]

Vyas "Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages" Int. J. Pharm. (2004) 10.1016/j.ijpharm.2003.08.017

[3]

Suarez "Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model" Pharm. Res. (2001) 10.1023/a:1013094112861

[4]

Suarez "Airways delivery of rifampicin microparticles for the treatment of tuberculosis" J. Antimicrob. Chemother. (2001) 10.1093/jac/48.3.431

[5]

Sharma "Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis" Pharm. Res. (2001) 10.1023/a:1012296604685

[6]

Fiegel "Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs" J. Control. Release (2004) 10.1016/j.jconrel.2004.02.018

[7]

Dutt "Therapeutic efficacy of poly(dl-lactide-co-glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice" Antimicrob. Agents Chemother. (2001) 10.1128/aac.45.1.363-366.2001

[8]

Ann Dailey "Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features" J. Control. Release (2003) 10.1016/s0168-3659(02)00370-x

[9]

Handbook of Air Pollution USP9990AP-44, 1968.

[10]

O’Hara "Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization" Pharm. Res. (2000) 10.1023/a:1007527204887

[11]

Makino "Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin" Colloids Surf. B (2004) 10.1016/j.colsurfb.2004.03.018

[12]

Ito "Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres" Colloids Surf. B (2004) 10.1016/j.colsurfb.2004.08.016

[13]

Tomoda "Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres" Colloids Surf. B: Biointerf. (2005) 10.1016/j.colsurfb.2005.06.014

[14]

Kamm "Is airway closure caused by a liquid film instability?" Respir. Physiol. (1989) 10.1016/0034-5687(89)90059-5

[15]

Bredenberg "Microvascular membrane permeability in high surface tension pulmonary edema" J. Appl. Physiol. (1986) 10.1152/jappl.1986.60.1.253

[16]

Clements "Pulmonary edema and permeability of alveolar membranes" Arch. Environtal Health (1961)

[17]

Pison "Host defense capacities of pulmonary surfactant-evidence for “non-surfactant” functions of the surfactant system" Eur. J. Clin. Invest. (1994) 10.1111/j.1365-2362.1994.tb01110.x

[18]

Pison "The pulmonary surfactant system: biological functions, components, physicochemical properties and alterations during lung disease" Colloids Surf. A: Physicochem. Eng. Aspects (1996) 10.1016/0927-7757(96)03572-8

[19]

Batenburg "Surfactant phospholipids: synthesis and storage" Am. J. Physiol.-Lung Cell. Mol. Physiol. (1992) 10.1152/ajplung.1992.262.4.l367

[20]

King "Lipid synthesis and surfactant turnover in the lungs" (1985)

[21]

Brown "Isolation and assay of dipalmityl lecithin in lung extracts" Am. J. Physiol. (1963) 10.1152/ajplegacy.1964.207.2.402

[22]

Ansfield "Identification of the immunosuppressive components of canine pulmonary surface active material" J. Immunol. (1980) 10.4049/jimmunol.125.3.1093

[23]

Wright "Surfactant apoprotein Mr=26,000–36,000 enhances uptake of liposomes by type II cells" J. Biol. Chem. (1987) 10.1016/s0021-9258(18)61590-x

[24]

Nagashima "Surface properties of monodisperse poly(acrylamide-co-acrylic acid) hydrogel microspheres prepared by a membrane emulsification technique" Colloids Surf. A: Physicochem. Eng. Aspects (1999) 10.1016/s0927-7757(98)00446-4

[25]

Dependence of Temperature-Sensitivity of Poly(N-isopropylacrylamide-co-acrylic acid) Hydrogel Microspheres upon Their Sizes

Kimiko Makino, Hideki Agata, Hiroyuki Ohshima

Journal of Colloid and Interface Science 2000 10.1006/jcis.2000.7084

[26]

K. Miyajima, Role of saccharides for the freeze-thawing and freeze drying of liposome, advanced drug delivery reviews 24 (1997) 151–159. 10.1016/s0169-409x(96)00454-1

[27]

Wolkers "Preservation of dried liposomes in the presence of sugar and phosphate" Biochim. Biophys. Acta (2004) 10.1016/j.bbamem.2003.12.006

[28]

Sahoo "Residual polyvinyl alcohol associated with poly(d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake" J. Control. Release (2002) 10.1016/s0168-3659(02)00127-x

[29]

Ohshima "Electrophoretic mobility of soft particles" J. Colloid Interf. Sci. (1994) 10.1006/jcis.1994.1126

[30]

Makino "Change in electrophoretic mobility of HL-60RG cells by apoptosis" Colloid Polym. Sci. (1994) 10.1007/bf00659462

[31]

Makino "Electro-osmotic studies of endothelial cell surface" Colloids Surf. B: Biointerf. (1996) 10.1016/0927-7765(96)01303-3

Metrics

40

Citations

31

References

Details

Published: Mar 01, 2007
Vol/Issue: 55(1)
Pages: 115-124
License: View

Authors

K

Keishiro Tomoda

Tokyo University of Science; Tokyo University of Science; Tokyo University of Science

K

Kimiko Makino

Tokyo University of Science; Tokyo University of Science; Tokyo University of Science

Cite This Article

Keishiro Tomoda, Kimiko Makino (2007). Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres. Colloids and Surfaces B: Biointerfaces, 55(1), 115-124. https://doi.org/10.1016/j.colsurfb.2006.11.030

Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres

You May Also Like